vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $223.8M, roughly 1.7× SILVERCORP METALS INC). SILVERCORP METALS INC runs the higher net margin — -1.3% vs -19.6%, a 18.3% gap on every dollar of revenue. Over the past eight quarters, SILVERCORP METALS INC's revenue compounded faster (87.6% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.
PIII vs SVM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $223.8M |
| Net Profit | $-75.5M | $-2.9M |
| Gross Margin | — | — |
| Operating Margin | -40.0% | — |
| Net Margin | -19.6% | -1.3% |
| Revenue YoY | 3.8% | — |
| Net Profit YoY | -28.8% | — |
| EPS (diluted) | $-23.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $223.8M | ||
| Q3 25 | $345.3M | — | ||
| Q2 25 | $355.8M | $72.2M | ||
| Q1 25 | $373.2M | — | ||
| Q4 24 | $370.7M | $172.5M | ||
| Q3 24 | $362.1M | $114.0M | ||
| Q2 24 | $379.2M | $60.0M | ||
| Q1 24 | $388.5M | — |
| Q4 25 | $-75.5M | $-2.9M | ||
| Q3 25 | $-31.6M | — | ||
| Q2 25 | $-20.4M | $28.1M | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | $-58.6M | $42.1M | ||
| Q3 24 | $-46.5M | $28.0M | ||
| Q2 24 | $-12.0M | $13.2M | ||
| Q1 24 | $-18.7M | — |
| Q4 25 | -40.0% | — | ||
| Q3 25 | -12.8% | — | ||
| Q2 25 | -9.6% | — | ||
| Q1 25 | -10.2% | — | ||
| Q4 24 | -37.4% | 30.5% | ||
| Q3 24 | -29.5% | 30.7% | ||
| Q2 24 | -8.3% | 30.0% | ||
| Q1 24 | -11.3% | — |
| Q4 25 | -19.6% | -1.3% | ||
| Q3 25 | -9.1% | — | ||
| Q2 25 | -5.7% | 39.0% | ||
| Q1 25 | -5.5% | — | ||
| Q4 24 | -15.8% | 24.4% | ||
| Q3 24 | -12.8% | 24.5% | ||
| Q2 24 | -3.2% | 22.0% | ||
| Q1 24 | -4.8% | — |
| Q4 25 | $-23.08 | — | ||
| Q3 25 | $-9.67 | — | ||
| Q2 25 | $-6.23 | — | ||
| Q1 25 | $-6.28 | — | ||
| Q4 24 | $-23.13 | — | ||
| Q3 24 | $-15.70 | — | ||
| Q2 24 | $-7.37 | — | ||
| Q1 24 | $-7.86 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | — |
| Total DebtLower is stronger | $228.4M | — |
| Stockholders' EquityBook value | $-155.2M | — |
| Total Assets | $656.6M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | — | ||
| Q3 25 | $37.7M | — | ||
| Q2 25 | $38.6M | — | ||
| Q1 25 | $40.1M | — | ||
| Q4 24 | $38.8M | — | ||
| Q3 24 | $63.0M | — | ||
| Q2 24 | $73.1M | — | ||
| Q1 24 | $27.3M | — |
| Q4 25 | $228.4M | — | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | — | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
| Q4 25 | $-155.2M | — | ||
| Q3 25 | $-18.7M | — | ||
| Q2 25 | $44.5M | — | ||
| Q1 25 | $63.3M | — | ||
| Q4 24 | $75.9M | — | ||
| Q3 24 | $120.5M | — | ||
| Q2 24 | $166.8M | — | ||
| Q1 24 | $146.6M | — |
| Q4 25 | $656.6M | — | ||
| Q3 25 | $683.6M | — | ||
| Q2 25 | $731.6M | — | ||
| Q1 25 | $783.9M | — | ||
| Q4 24 | $783.4M | — | ||
| Q3 24 | $833.3M | — | ||
| Q2 24 | $892.8M | — | ||
| Q1 24 | $855.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $107.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $107.9M | ||
| Q3 25 | $-15.4M | — | ||
| Q2 25 | $-16.6M | $40.0M | ||
| Q1 25 | $-33.5M | — | ||
| Q4 24 | $-57.2M | $81.3M | ||
| Q3 24 | $-22.6M | $57.7M | ||
| Q2 24 | $-10.2M | $28.9M | ||
| Q1 24 | $-20.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $33.8M | ||
| Q2 24 | — | $17.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 21.0% | ||
| Q2 24 | 0.0% | 19.8% | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 2.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
SVM
Segment breakdown not available.
